Cargando…

Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver Cirrhosis

BACKGROUND: Bacterial infections are associated with the risk of variceal bleeding through complex pathophysiologic pathways. OBJECTIVES: The primary objective of the present case-control study was to investigate the role of bacterial translocation and intestinal barrier dysfunction in the pathogene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Triantos, Christos, Kalafateli, Maria, Assimakopoulos, Stelios F., Karaivazoglou, Katerina, Mantaka, Aikaterini, Aggeletopoulou, Ioanna, Spantidea, Panagiota I., Tsiaoussis, Georgios, Rodi, Maria, Kranidioti, Hariklia, Goukos, Dimitrios, Manolakopoulos, Spilios, Gogos, Charalambos, Samonakis, Dimitrios N., Daikos, Georgios L., Mouzaki, Athanasia, Thomopoulos, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929724/ https://www.ncbi.nlm.nih.gov/pubmed/35308545 http://dx.doi.org/10.3389/fmed.2022.836306

Ejemplares similares

Bacterial load and cytokine profile in patients with cirrhosis following therapy with proton pump inhibitors: a prospective cohort study
por: Triantos, Christos, et al.
Publicado: (2017)

Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis
por: Triantos, Christos, et al.
Publicado: (2018)

Natural history of grade 1 ascites in patients with liver cirrhosis
por: Theodorakopoulos, Theodoros, et al.
Publicado: (2021)

Epidemiology of hepatitis C in Greece
por: Triantos, Christos, et al.
Publicado: (2016)

Muscle fat infiltration assessed by total psoas density on computed tomography predicts mortality in cirrhosis
por: Kalafateli, Maria, et al.
Publicado: (2018)

Vitamin D–VDR Novel Anti-Inflammatory Molecules—New Insights into Their Effects on Liver Diseases
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2022)

miRNA Molecules—Late Breaking Treatment for Inflammatory Bowel Diseases?
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors
por: Kranidioti, Hariklia, et al.
Publicado: (2015)

Role of band ligation for secondary prophylaxis of variceal bleeding
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2018)

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2017)

Propranolol reduces systemic oxidative stress and endotoxemia in cirrhotic patients with esophageal varices
por: Taprantzi, Dimitra, et al.
Publicado: (2018)

Alexithymic characteristics and interoceptive abilities are associated with disease severity and levels of C-reactive protein and cytokines in patients with inflammatory bowel disease
por: Vinni, Eleni, et al.
Publicado: (2023)

Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential
por: Eleftheriotis, Gerasimos, et al.
Publicado: (2023)

Creeping Fat in Crohn’s Disease—Surgical, Histological, and Radiological Approaches
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2018)

Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs
por: Siakavellas, Spyros, et al.
Publicado: (2021)

Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein
por: Deutsch, Melanie, et al.
Publicado: (2018)

Elastography for Hepatic Fibrosis Severity in Chronic Hepatitis B or C
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2011)

The Impact of Host Metabolic Factors on Treatment Outcome in Chronic Hepatitis C
por: Savvoula, Savvidou, et al.
Publicado: (2012)

Direct-acting antiviral treatment for chronic hepatitis C in people who use drugs in a real-world setting
por: Koustenis, Kanellos Rafail, et al.
Publicado: (2020)

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

The Role of the Gut Barrier Function in Health and Disease
por: Assimakopoulos, Stelios F., et al.
Publicado: (2018)

Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues
por: Papadopoulos, Nikolaos, et al.
Publicado: (2018)

Patterns, Cost, and Immunological Response of MDR vs. Non MDR-Bacteremia: A Prospective Cohort Study
por: Schinas, Georgios, et al.
Publicado: (2023)

NAFLD and HBV interplay - related mechanisms underlying liver disease progression
por: Tourkochristou, Evanthia, et al.
Publicado: (2022)

The Influence of Single Nucleotide Polymorphisms on Vitamin D Receptor Protein Levels and Function in Chronic Liver Disease
por: Tourkochristou, Evanthia, et al.
Publicado: (2023)

Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis
por: Kranidioti, Hariklia, et al.
Publicado: (2018)

Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges
por: Mantaka, Aikaterini, et al.
Publicado: (2018)

The role of vitamin D receptor polymorphisms in the course of chronic hepatitis C infection
por: Tsounis, Efthymios P., et al.
Publicado: (2022)

Serum zonulin levels in patients with liver cirrhosis: Prognostic implications
por: Voulgaris, Theodoros A, et al.
Publicado: (2021)

Shifting gears: Study of immune system parameters of male habitual marathon runners
por: Panagoulias, Ioannis, et al.
Publicado: (2023)

The Influence of Nutritional Factors on Immunological Outcomes
por: Tourkochristou, Evanthia, et al.
Publicado: (2021)

Unveiling the biological role of sphingosine-1-phosphate receptor modulators in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2023)

Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression
por: Tourkochristou, Evanthia, et al.
Publicado: (2023)

Health-related quality of life in patients with inflammatory bowel disease: a single-center experience
por: Kalafateli, Maria, et al.
Publicado: (2013)

Νon-invasive screening for esophageal varices in patients with liver cirrhosis
por: Karatzas, Andreas, et al.
Publicado: (2018)

Ets-2 Acts As a Transcriptional Repressor of the Human Immunodeficiency Virus Type 1 through Binding to a Repressor–Activator Target Sequence of 5′-LTR
por: Panagoulias, Ioannis, et al.
Publicado: (2018)

Nucleic acid vaccines: A taboo broken and prospect for a hepatitis B virus cure
por: Tsounis, Efthymios P, et al.
Publicado: (2021)

Adiposity factors are not related to the presence of colorectal adenomas
por: Chronis, Aris, et al.
Publicado: (2011)

Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience
por: Manolakopoulos, Spilios, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oaa25iq9kvhk1jood7j4rve0ki